Lv6
1680 积分 2025-01-17 加入
Pembrolizumab plus chemotherapy versus placebo plus chemotherapy for previously untreated locally recurrent inoperable or metastatic triple-negative breast cancer (KEYNOTE-355): a randomised, placebo-controlled, double-blind, phase 3 clinical trial
4天前
已完结
Pembrolizumab plus chemotherapy versus placebo plus chemotherapy for previously untreated locally recurrent inoperable or metastatic triple-negative breast cancer (KEYNOTE-355): a randomised, placebo-controlled, double-blind, phase 3 clinical trial
4天前
已完结
Advances in Systemic Treatment of Breast Cancer
18天前
已完结
Deep learning using histological images for gene mutation prediction in lung cancer: a multicentre retrospective study
1个月前
已完结
The changing therapeutic landscape of small-cell lung cancer
1个月前
已完结
TIGIT’s immuno-oncology teachings
1个月前
已完结
Claudin-18 isoform 2-specific CAR T-cell therapy (satri-cel) versus treatment of physician's choice for previously treated advanced gastric or gastro-oesophageal junction cancer (CT041-ST-01): a randomised, open-label, phase 2 trial
1个月前
已完结
Claudin-18 isoform 2-specific CAR T-cell therapy (satri-cel) versus treatment of physician's choice for previously treated advanced gastric or gastro-oesophageal junction cancer (CT041-ST-01): a randomised, open-label, phase 2 trial
1个月前
已完结
Neutrophils in cancer
2个月前
已完结
Clinical development of cancer vaccines
2个月前
已完结
皖公网安备34019202002308
